beta-Ketonitriles are important precursors for a wide variety of biologically active heterocycles. A facile procedure for the high-yielding acylation of nitrile anions with unactivated esters to provide beta-ketonitriles is reported. The procedure is successful with enolizable and nonenolizable esters as well as hindered nitrile anions.
The present disclosure provides MAT2A inhibitor compounds that are useful as therapeutic agents for treating malignancies, and wherein the compounds conform to general formula (IA):
wherein RA, RB, RC, RD, and RE are defined herein.
本公开提供了可作为治疗剂用于治疗恶性肿瘤的 MAT2A 抑制剂化合物,其中的化合物符合通式 (IA):
其中 RA、RB、RC、RD 和 RE 在本文中定义。
INHIBITORS OF CELLULAR METABOLIC PROCESSES
申请人:Agios Pharmaceuticals, Inc.
公开号:EP3507290A1
公开(公告)日:2019-07-10
[EN] INHIBITORS OF CELLULAR METABOLIC PROCESSES<br/>[FR] INHIBITEURS DE PROCESSUS MÉTABOLIQUES CELLULAIRES
申请人:AGIOS PHARMACEUTICALS INC
公开号:WO2018045071A1
公开(公告)日:2018-03-08
The present disclosure provides MAT2A inhibitor compounds that are useful as therapeutic agents for treating malignancies, and wherein the compounds conform to general formula (IA), wherein RA, RB, RC, RD, and RE are defined herein.
A High-Yielding Preparation of β-Ketonitriles
作者:Yaohui Ji、William C. Trenkle、James V. Vowles
DOI:10.1021/ol053164z
日期:2006.3.1
beta-Ketonitriles are important precursors for a wide variety of biologically active heterocycles. A facile procedure for the high-yielding acylation of nitrile anions with unactivated esters to provide beta-ketonitriles is reported. The procedure is successful with enolizable and nonenolizable esters as well as hindered nitrile anions.